Cite
Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitors.
MLA
Shirayama, Rie, et al. “Perioperative Safety and Haematostatic Efficacy of a New Bypassing Agent Pd-FVIIa/FX (Byclot) in Haemophilia Patients with High-Responding Type Inhibitors.” Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis, vol. 30, no. 8, Dec. 2019, pp. 385–92. EBSCOhost, https://doi.org/10.1097/MBC.0000000000000851.
APA
Shirayama, R., Takedani, H., Chikasawa, Y., Ishiguro, A., Ishimura, M., Isobe, K., Uchiba, M., Ogata, Y., Kakuda, H., Kusuhara, K., & Shirahata, A. (2019). Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitors. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis, 30(8), 385–392. https://doi.org/10.1097/MBC.0000000000000851
Chicago
Shirayama, Rie, Hideyuki Takedani, Yushi Chikasawa, Akira Ishiguro, Masataka Ishimura, Kiyotaka Isobe, Mitsuhiro Uchiba, et al. 2019. “Perioperative Safety and Haematostatic Efficacy of a New Bypassing Agent Pd-FVIIa/FX (Byclot) in Haemophilia Patients with High-Responding Type Inhibitors.” Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis 30 (8): 385–92. doi:10.1097/MBC.0000000000000851.